REFERENCES
1. Centers for Disease Control and Prevention. HIV Infection, Risk, Prevention, and Testing Behaviors Among Transgender Women—National HIV Behavioral Surveillance, 7 U.S. Cities, 2019-2020.
HIV Surveillance Special Report 27 http://www.cdc.gov/hiv/library/reports/hiv- surveillance.html. 2021. Accessed September 20 2021.2. The GenIUSS Group. Best Practices for Asking Questions to Identify Transgender and Other Gender Minority Respondents on Population-Based Surveys. CAThe Williams Institute; 2014. https://williamsinstitute.law.ucla.edu/wp-content/uploads/geniuss-report-sep-2014.pdf
3. Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis. NEngl JMed. 2020;382(9):845- 854. PMID: 32101666. doi: 10.1056/NEJMra1901593
4. Centers for Disease Control and Prevention - Sexually Transmitted Diseases Surveillance Report 2019. Published April 2021. https://www.cdc.gov/std/statistics/2019/default.htm
5. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(No. RR-4):1-187. doi:10.15585/mmwr.rr7004a1
6. Ward H, Martin I, Macdonald N, et al. Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis. 2007;44(1):26-32.
7. De voux A, Kent JB, Macomber K, et al. Notes from the field: cluster of lymphogranuloma venereum cases among men who have sex with men—Michigan, August 2015-April 2016. MMWR Morb Mortal Wkly Rep. 2016;65(34):920-921.
8. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19.
9. World Health Organization. HIV/AIDS: Data and Statistics. Updated July 2021. https://www.who.int/data/gho/data/themes/hiv-aids
10. Centers for Disease Control and Prevention. Accessed April 2022.
http: //www.cdc. gov/hiv/group/gender/women/diagnoses.html
11.
Centers for Disease Control and Prevention. Accessed April 2022.https: //www.cdc. gov/hiv/group/msm/index.html
12. Centers for Disease Control and Prevention: US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update - A Clinical Practice Guideline. 2018. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf
13. DiNenno EA, Prejean J, Irwin K, et al. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men — United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:830-832. doi:10.15585/mmwr.mm6631a3
14. Thompson MA, Horberg MA, Agwu AL, et al. Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV medicine association of the infectious diseases
SocietyofAmerica. Clin Infect Dis. 2020;73(11):e3572-e3605. doi:10.1093/cid/ciaa1391
15. International Antiviral Society-USA. Guidelines. 2020. http://www.iasusa.org/guidelines/
16. U.S. Department of Health and Human Services. Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. 2020. http://aidsinfo.nih.gov/guidelines/html/3/perinatal- guidelines/0
17. Friis-moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients- association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17(8):1179-1193.
18. Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Accessed February 1, 2021. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
19. Centers for Disease Control and Prevention. Human Papillomavirus (HPV). 2017. http: //www.cdc. gov/std/hpv/treatment.htm